Vaxcyte, Inc.·4

Jan 2, 4:21 PM ET

Dhaliwal Harpreet S. 4

4 · Vaxcyte, Inc. · Filed Jan 2, 2026

Insider Transaction Report

Form 4
Period: 2025-12-31
Dhaliwal Harpreet S.
Chief Technical Ops Officer
Transactions
  • Sale

    Common Stock

    2025-12-31$46.69/sh9,743$454,89123,928 total
Footnotes (2)
  • [F1]The price reported is a weighted-average price. The shares were sold at prices ranging from $46.42 to $47.155. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F2]Includes one (1) share acquired on November 17, 2025 under the Issuer's Employee Stock Purchase Plan.

Documents

1 file
  • 4
    wk-form4_1767388912.xmlPrimary

    FORM 4